Paraoxonase-1 and arylesterase levels in patients with ulcerative

被引:4
|
作者
Sahin, Memduh [1 ]
Bobusoglu, Onur [2 ]
Yetim, Aylin [3 ]
Ates, Fehmi [4 ]
机构
[1] Saglik Bilimleri Univ, Dept Gastroenterol, Sisli Hamidiye Etfal Training & Res Hosp, Istanbul, Turkey
[2] Mersin Univ, Dept Biochem, Mersin, Turkey
[3] Istanbul Univ, Dept Adeloscent Hlth, Istanbul, Turkey
[4] Mersin Univ, Dept Gastroenterol, Mersin, Turkey
关键词
Ulcerative colitis; Oxidative stress; Paraoxonase; Arylesterase; INFLAMMATORY-BOWEL-DISEASE; OXIDATIVE STRESS; CROHNS-DISEASE;
D O I
10.1016/j.ajg.2019.01.009
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and study aims: The role of oxidative stress in inflammatory bowel disease is increasingly recognised as an important factor. It is assumed that reduced levels of paraoxonase-1 (PON-1) and arylesterase (ARE) may lead to increased inflammation due to increased oxidative stress. This study aimed to investigate the relationship between ARE and PON-1 levels in ulcerative colitis (UC) patients and the difference in these levels in UC patients in comparison to the control group. Patients and methods: The study population consisted of 66 (73.3%) UC patients and 24 (26.7%) healthy individuals as the control group. The UC patients and the control group were compared in terms of PON-1 and ARE levels as oxidative stress markers. The UC patients were also grouped according to Mayo UC activity scores, and the differences in their PON-1 and ARE levels were assessed. Results: The ARE values were statistically higher in the control group in comparison to the UC patients. Concentrations of PON-1 were not statistically different in the UC and control groups. The ARE value was found to be significantly lower in the UC patients with a haemoglobin level below 10 mg/dl. There was a correlation between the ARE and PON-1 values in the UC patients, but there was no difference between the ARE and PON-1 values, based on the UC patients' Mayo disease severity scores. Conclusion: This study found that the ARE values of UC patients were lower than those of healthy subjects. The same results could not be determined for PON-1. The data suggest that the antioxidative capacity of UC patients may be reduced. (C) 2019 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:14 / 18
页数:5
相关论文
共 50 条
  • [1] Paraoxonase-1 and arylesterase activities in patients with colorectal cancer
    Afsar, Cigdem Usul
    Gunaldi, Meral
    Okuturlar, Yildiz
    Gedikbasi, Asuman
    Tiken, Elif Eda
    Kahraman, Sibel
    Karaca, Feryal
    Ercolak, Vehbi
    Karabulut, Mehmet
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (11): : 21599 - 21604
  • [2] Arylesterase and Paraoxonase-1 Activities in Female Patients with Temporomandibular Disorders
    Etoez, Osman A.
    Ataoglu, Hanife
    Herken, Emine Nur
    Celik, Hakim
    JOURNAL OF MUSCULOSKELETAL PAIN, 2009, 17 (03): : 239 - 245
  • [3] Quantification of the arylesterase activity of paraoxonase-1 in human blood
    Dias, Clara G.
    Batuca, Joana R.
    Marinho, Aline T.
    Caixas, Umbelina
    Monteiro, Emilia C.
    Antunes, Alexandra M. M.
    Pereira, Sofia A.
    ANALYTICAL METHODS, 2014, 6 (01) : 289 - 294
  • [4] Paraoxonase-1 arylesterase activity is an independent predictor of myeloperoxidase levels in overweight patients with or without cardiovascular complications
    Zsiros, Noemi
    Koncsos, Peter
    Lorincz, Hajnalka
    Seres, Ildiko
    Katko, Monika
    Szentpeteri, Anita
    Varga, Viktoria E.
    Fulop, Peter
    Paragh, Gyorgy
    Harangi, Mariann
    CLINICAL BIOCHEMISTRY, 2016, 49 (12) : 862 - 867
  • [5] Paraoxonase-1 (PON-1) Arylesterase Activity Levels in Patients with Coronary Artery Disease: A Meta-Analysis
    Zuin, Marco
    Trentini, Alessandro
    Marsillach, Judit
    D'Amuri, Andrea
    Bosi, Cristina
    Roncon, Loris
    Passaro, Angelina
    Zuliani, Giovanni
    Mackness, Mike
    Cervellati, Carlo
    DISEASE MARKERS, 2022, 2022
  • [6] Paraoxonase, arylesterase and lactonase activities of paraoxonase-1 (PON1) in obese and severely obese women
    Cervellati, Carlo
    Bonaccorsi, Gloria
    Trentini, Alessandro
    Valacchi, Giuseppe
    Sanz, Juana M.
    Squerzanti, Monica
    Spagnolo, Manuela
    Massari, Leo
    Crivellari, Ilaria
    Greco, Pantaleo
    Parladori, Roberta
    Passaro, Angelina
    Ricci, Giorgio
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2018, 78 (1-2): : 18 - 24
  • [7] Paraoxonase/Arylesterase Activity of Serum Paraoxonase-1 and Schizophrenia: A Systematic Review and Meta-Analysis
    Zinellu, Angelo
    Sedda, Stefania
    Mangoni, Arduino A.
    ANTIOXIDANTS, 2023, 12 (08)
  • [8] Effect of lipoic acid on paraoxonase-1 and paraoxonase-3 protein levels, mRNA expression and arylesterase activity in liver hepatoma cells
    Ozgun, Eray
    Ozgun, Gulben Sayilan
    Tabakcioglu, Kiymet
    Gokmen, Selma Suer
    Sut, Necdet
    Eskiocak, Sevgi
    GENERAL PHYSIOLOGY AND BIOPHYSICS, 2017, 36 (04) : 465 - 470
  • [9] Serum Arylesterase, Paraoxonase, and Lactonase Activities and Paraoxonase-1 Concentrations in Morbidly Obese Patients and Their Relationship with Non-Alcoholic Steatohepatitis
    Castane, Helena
    Jimenez-Franco, Andrea
    Martinez-Navidad, Cristian
    Placed-Gallego, Cristina
    Cambra-Cortes, Vicente
    Perta, Adelina-Miruna
    Paris, Marta
    Castillo, Daniel del
    Arenas, Meritxell
    Camps, Jordi
    Joven, Jorge
    ANTIOXIDANTS, 2023, 12 (12)
  • [10] Low Serum Paraoxonase-1 Lactonase and Arylesterase Activities in Obese Children and Adolescents
    Sandor, Raluca
    Leucuta, Daniel
    Dronca, Eleonora
    Niculae, Alexandru
    Cret, Victoria
    Silaghi, Ciprian
    Suciu, Soimita
    REVISTA ROMANA DE MEDICINA DE LABORATOR, 2015, 23 (04): : 385 - 395